|
|
|
Volumn 4, Issue 4, 1998, Pages 226-229
|
|
Multimodality therapy for esophageal cancer: An emerging role
a
a
MC 2115
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
VINBLASTINE;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
ESOPHAGUS CANCER;
ESOPHAGUS RESECTION;
GASTROINTESTINAL TOXICITY;
HUMAN;
LOWER ESOPHAGUS SPHINCTER;
MULTIMODALITY CANCER THERAPY;
NOTE;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
ESOPHAGEAL NEOPLASMS;
HUMANS;
MEDICAL ONCOLOGY;
|
|
EID: 0031902261
PISSN: 10814442
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (32)
|
